A detailed history of James J. Burns & Company, LLC transactions in Pfizer Inc stock. As of the latest transaction made, James J. Burns & Company, LLC holds 14,439 shares of PFE stock, worth $428,260. This represents 0.08% of its overall portfolio holdings.

Number of Shares
14,439
Previous 13,945 3.54%
Holding current value
$428,260
Previous $384,000 5.21%
% of portfolio
0.08%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$25.26 - $29.6 $12,478 - $14,622
494 Added 3.54%
14,439 $404,000
Q1 2024

Apr 23, 2024

SELL
$25.89 - $29.73 $4,012 - $4,608
-155 Reduced 1.1%
13,945 $384,000
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $368,433 - $478,553
14,100 New
14,100 $405,000
Q2 2023

Jul 27, 2023

BUY
$36.12 - $41.79 $21,202 - $24,530
587 Added 11.81%
5,557 $203,000
Q1 2023

Apr 24, 2023

BUY
$39.39 - $51.28 $195,768 - $254,861
4,970 New
4,970 $203,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track James J. Burns & Company, LLC Portfolio

Follow James J. Burns & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James J. Burns & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on James J. Burns & Company, LLC with notifications on news.